A temporal trend analysis of breast and prostate cancer mortality rates in Lithuania, 1986-2020 | BMC Public Health

[ad_1]

  • Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.

    CAS Google Scholar Article

  • Wojtyla C, Bertuccio P, Wojtyla A, La Vecchia C. European trends in breast cancer mortality, 1980-2017 and forecasts to 2025. Eur J Cancer. 2021;152:4–17.

    Google Scholar article

  • Bertuccio P, Santucci C, Carioli G, Malvezzi M, La Vecchia C, Negri E. Trends in mortality from urological cancers in Europe over the period 1980-2017 and projection until 2025. Eur Urol Oncol. 2021;4(5):677–96.

    Google Scholar article

  • Sebuødegård S, Botteri E, Hofvind S. Breast cancer mortality after the implementation of population-based organized breast cancer screening in Norway. J Natl Cancer Institute 2020; 112(8): 839–846. Erratum in: J Natl Cancer Inst 2020;112(10):1072–4.

  • Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and forecasts until 2020 of breast cancer mortality in Europe. Breast. 2017;36:89–95.

    Google Scholar article

  • Kvåle R, Myklebust TA, Engholm G, Heinävaara S, Wist E, Møller B. Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and groups age 1975-2013. Int J Cancer. 2017;141:2228–42.

    Google Scholar article

  • López-Abente G, Mispireta S, Pollán M. Breast and prostate cancer: analysis of common epidemiological characteristics of mortality trends in Spain. BMC Cancer. 2014;14:874.

    Google Scholar article

  • Welch HG, Albertsen PC. Reconsidering prostate cancer mortality – the future of PSA screening. N Engl J Med. 2020;382(16):1557–63.

    Google Scholar article

  • Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308–47.

    Google Scholar article

  • Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global trends in prostate cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52.

    Google Scholar article

  • Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H. Cancer surveillance using registry data: results and recommendations for the Lithuanian national program for early detection of prostate cancer. Eur J Cancer. 2015;51(12):1630–7.

    Google Scholar article

  • Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic and biochemical characteristics. Endocr Rev. 1998;19(4):365–96.

    Google Scholar article

  • National Health Insurance Fund under the Ministry of Health of Lithuania. Performance of the breast cancer screening program in Lithuania in 2019. Available at: https://ligoniukasa.lrv.lt/uploads/ligoniukasa/documents/files/Veiklos_sritys/Ligu_prevencijos_programos/0324%202019%20patikros%20d%C4%97l %20kr%20v %C4%97%C5%BEio%20atask.pdf. Accessed January 18, 2022. in Lithuanian.

  • Ponti A, Anttila A, Ronco G, Senore C, Basu P, Segnan N, Tomatis M, Žakelj MP, Dillner J, Fernan M, Elfström KM, Lönnberg S, Soerjomataram I, Vale D. Cancer screening in the European Union . Report on the implementation of the Council recommendation on cancer screening. Lyon: International Agency for Research on Cancer, 2017. 313.

  • Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, et al. Incidence of prostate cancer in 43 world populations: an analysis of global and age-group temporal trends. Int J Cancer. 2016;138:1388–400.

    CAS Google Scholar Article

  • Innos K, Baburin A, Kotsar A, Eiche IE, Lang K. Prostate cancer incidence, mortality and survival trends in Estonia, 1995-2014. Scand J Urol. 2017;51(6):442–9.

    Google Scholar article

  • Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-year follow-up of the European Randomized Prostate Cancer Screening Study. Eur Urol. 2019;76:43–51.

    Google Scholar article

  • Van Poppel H, Roobol MJ, Chapple CR, Catto JWF, N’Dow J, Sønksen J, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: position and recommendations of the European Urological Association for 2021. Eur Urol. 2021;80(6):703–11.

    Google Scholar article

  • Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Screening for prostate cancer with the prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;5(362):k3519. https://doi.org/10.1136/bmj.k3519.

    Google Scholar article

  • EU Council Recommendation on cancer screening of 2 December 2003. (2003/878/EC). Official Journal of the European Union 16.12.2003. https://ec.europa.eu/jrc/sites/default/files/2_December_2003%20cancer%20screening.pdf. Accessed October 26, 2021.

  • Mottet N, Cornford P, van den Bergh RCN, Briers E, De Santis M, Gillessen S, Grummet J, Henry A. M, van der Kwast TH, Lam TB, Mason MD, O’Hanlon S, Oprea-Lager DE, Ploussard G, van der Poel HG, Rouvière O, Schoots IG, Tilki D, Wiegel T, Van den Broeck T, Cumberbatch M, Farolfi A, Fossati N, Gandaglia G, Grivas N, Lardas M, Liew M, Moris L, Willemse PP.M. EAU-EANM-ESTRO-ESUR-ISUP-SIOG recommendations on prostate cancer. Arnhem, The Netherlands: European Association of Urology, 2021. https://uroweb.org/wp-content/uploads/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2021V3. pdf. Accessed January 18, 2022.

  • Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. A European model for an organized risk-stratified early detection program for prostate cancer. Eur Urol Oncol. 2021;4(5):731–9.

    Google Scholar article

  • European code against cancer. International Agency for Research on Cancer. https://cancer-code-europe.iarc.fr/index.php/en/ecac-12-ways. Accessed January 18, 2022.

  • Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, et al. STHLM3 Consortium. Targeted or standard biopsy by MRI in the context of prostate cancer screening. N Engl J Med. 2021;385(10):908–20.

    Google Scholar article

  • National Health Insurance Fund under the Ministry of Health of Lithuania. Performance of the prostate cancer screening program in Lithuania in 2019. Available at: https://ligoniukasa.lrv.lt/uploads/ligoniukasa/documents/files/Veiklos_sritys/Ligu_prevencijos_programos/2019%20m_%20prie%C5%A1in% C4%97s%20liaukos%20v%C4%97%C5%BEio%20ankstyvosios%20diagnostikos%20programos%20ataskaita.pdf. Accessed January 18, 2022. in Lithuanian.

  • Everatt R, Kuzmickienė I, Intaitė B, Anttila A. Effectiveness of cervical cancer prevention program: a case-control audit of mortality in Lithuania. Eur J Cancer Prev. 2020;29(6):504–10.

    Google Scholar article

  • World Health Organization (WHO) database. https://www.who.int/data/data-collection-tools/who-mortality-database. Accessed March 24, 2022.

  • Statistics Lithuania. https://osp.stat.gov.lt/statistiniu-rodikliu-analize#/. Accessed January 18, 2022.

  • National Cancer Institute, Joinpoint Regression Program Version 4.5.0.1, June: National Cancer Institute, Bethesda (MD), 2017. https://surveillance.cancer.gov/joinpoint/.

  • Rosenberg PS, Check DP, Anderson WF. A web-based tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev 2014;23(11):2296–2302. https://doi.org/10.1158/1055-9965.EPI-14-0300.

  • Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Héry C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective analysis of trends from the WHO Mortality Database. BMJ. 2010;341:c3620.

    Google Scholar article

  • Malvezzi M, Carioli G, Bertuccio P, Negri E, La Vecchia C. Relationship between trends in mortality from cardiovascular diseases and certain cancers in the European Union, in 1970-2017. Focus on cohort and period effects. Eur J Cancer. 2018;103:341–55.

    CAS Google Scholar Article

  • Grabauskas V, Klumbienė J, Petkevičienė J, Šakytė E, Kriaučionienė V, Veryga V. Health behavior among Lithuanian adult population, 2014. Kaunas: Lithuanian University of Health Sciences, 2015. 146.

  • Grabauskas V, Klumbienė J, Petkevičienė J, Dregval L. Čepaitis Ž, Nedzelskienė I, Puska P, Uutela A, Helakorpi S. Health behavior among Lithuanian adult population, 1994. Kaunas Medical Academy, Lithuania. Helsinki: National Institute of Public Health, 1997.

  • The World Bank Group, 2022. https://data.worldbank.org/indicator/SP.DYN.CONU.ZS?locations=LT. Accessed January 20, 2022.

  • Steponaviciene L, Briediene R, Vanseviciute R, Smailyte G. Trends in breast cancer incidence and stage distribution before and during introduction of mammography screening program in Lithuania. Fight against cancer. 2019;26(1):1073274818821096. https://doi.org/10.1177/1073274818821096.

    PubMed Article PubMed Central Google Scholar

  • Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, et al. National health system characteristics, stage of breast cancer at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021;22(11):1632–42. https://doi.org/10.1016/S1470-2045(21)00462-9.

    PubMed Google Scholar article

  • Héry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 predominantly Caucasian countries. Anne Oncol. 2008;19(6):1187–94.

    Google Scholar article

  • Adliene D, Adlys G, Cerapaite R, Jonaitiene E, Cibulskaite I. Optimization of radiographic examinations in Lithuania: start of implementation in mammography. Radiat Prot Dosim. 2005;114(1–3):399–402. https://doi.org/10.1093/rpd/nch520.

    Google Scholar article

  • Grabauskas VJ, Klumbienė J, Petkevičienė J, Katvickis A, Šačkutė A, Helasoja V, et al. Prättälä Ritva. Health behavior among Lithuanian adult population, 2004. Helsinki: National Institute of Public Health; 2005. p. 164.

    Google Scholar

  • Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–92.

    Google Scholar article

  • Feuer EJ, Merrill RM, Hankey BF. Cancer Surveillance Series: Interpreting Prostate Cancer Trends – Part II: Misclassification of Causes of Death and Recent Rise and Fall in Prostate Cancer Mortality. J Natl Cancer Inst. 1999;91(12):1025–1032.

  • Patasius A, Krilaviciute A, Smailyte G. Screening for prostate cancer with PSA: ten years of experience from the population-based prostate cancer early detection program in Lithuania. J Clin Med. 2020;9(12):3826.

    Google Scholar article

  • Seikkula HA, Kaipia AJ, Ryynänen H, Seppä K, Pitkäniemi JM, Malila NK, et al. The impact of socioeconomic status on stage-specific prostate cancer survival and mortality before and after the introduction of PSA testing in Finland. Int J Cancer. 2018;142(5):891–8.

    CAS Google Scholar Article

  • Shoag JE, Nyame YA, Gulati R, Etzioni R, Hu JC. Reconsidering the trade-offs of prostate cancer screening. N Engl J Med. 2020;382(25):2465–8.

    Google Scholar article

  • [ad_2]
    Source link

    Comments are closed.